In the complex world of biologics manufacturing, cell line development (CLD) plays a crucial role in bringing new biologic therapies to patients.
Cellular Analysis Blog
Explore Cell Line Development Articles
Latest
Revolutionizing Bispecific Antibody Production Using the Beacon® Platform
Bispecific Antibodies: An Emerging Therapeutic Paradigm Bispecific antibodies (bsAbs) are rapidly gaining momentum in the pharmaceutical industry as a revolutionary class of therapeutics. While monoclonal antibodies (mAbs) have dominated the biologics landscape for decades, bsAbs offer unique therapeutic mechanisms by targeting two different antigens simultaneously. This capability enables novel treatment strategies, particularly in cancer immunotherapy, […]
Efficiency with Excellence: Expedite Cell Line Development Timelines with the Beacon® Platform’s Selective Cell Cloning
In the biopharmaceutical industry, where lengthy antibody therapeutic development timelines can delay critical treatments for patients in need, accelerating cell line development (CLD) has never been more crucial. The Beacon® optofluidic system by Bruker Cellular Analysis has emerged as a revolutionary platform, offering unparalleled efficiency in CLD processes by enabling a suite of powerful assays […]
Unlock the Phenome